At Dana-Farber Brigham Cancer Center, all we do is cancer. Because no two people are the same, our treatment isn’t one-size-fits-all. Each of our 13 specialized disease treatment centers are dedicated to providing individualized care for your type of cancer. We focus your treatment not only around your individual health care needs but also your unique lifestyle and goals.
Brigham and Women’s Hospital partners with Dana-Farber Cancer Institute to deliver adult cancer care. At Dana-Farber Brigham Cancer Center, our team of experts provides each patient with personalized, multidisciplinary cancer care.
The Center is recognized by U.S. News & World Report as one of the nation’s top five cancer centers. Dana-Farber Brigham Cancer Center’s clinical innovations include emerging cellular therapies, immuno-oncology in preoperative settings and adaptive radiation therapy. We also have the highest-volume CAR T-cell therapy center in New England and one of the largest nationally.
Don't delay your care. Call 857-255-1507 for an appointment to experience the difference of Dana-Farber Brigham Cancer Center.
You can also click the button below to submit an appointment request form. Schedulers from Brigham and Women’s Hospital will contact you to set up an appointment with our Dana-Farber Brigham Cancer Center specialists.
Thomas Clancy, MD, Director, Pancreas Surgery, Division of Surgical Oncology; Co-Director, Pancreas and Biliary Tumor Center, Dana-Farber Brigham Cancer Center, discusses minimally invasive robotic surgery for pancreatic and gastrointestinal cancers and what makes this one of the leading robotic programs in the northeast.
After years of being undiagnosed, Paul found out that he had an aggressive and rare form of prostate cancer. Thanks to Dana-Farber Brigham Cancer Center's expertise in treating complex and rare types of cancer, Paul is now in remission and back to enjoying life.
Breast cancer is the most common cancer affecting women worldwide and the incidence is increasing. In this Q&A with Marybeth Hans, MS, PA-C, Clinical Director of the Breast Cancer Personalized Risk Assessment, Education and Prevention Program (B-PREP), she discusses assessments for patients who might be at a high risk of developing breast cancer.
In light of recent news from the Dana-Farber Cancer Institute, which we currently collaborate with to provide medical oncology services to our patients with cancer, we are providing additional information to our patients and their families.
Click here to learn more about our commitment to cancer care.
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.
About BWH
